Все публикации

Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low an...

Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low an...

Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer

Addressing Current Questions and Controversies in the Management of Multiple Myeloma

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of...

Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of...

Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal an...

Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary...

Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic C...

Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis

5-Minute Journal Club: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastat...

AON 2024 | Hepatobiliary Cancers — Daneng Li, MD

AON 2024 | Gynecologic Cancers — Kathleen N Moore, MD, MS

AON 2024 | Leukemia and Myelodysplastic Syndromes — Harry Paul Erba, MD, PhD

AON 2024 | Antibody-Drug Conjugates in Lung Cancer — Edward B Garon, MD, MS

AON 2024 | Myelofibrosis — Stephen T Oh, MD, PhD

AON 2024 | Colorectal and Gastroesophageal Cancers — Christopher Lieu, MD

Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and ...

5-Minute Journal Club: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastat...

Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer

Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell L...